BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3338370)

  • 21. Protective effect of the PAF-antagonist BN 52021 on several models of gastro-intestinal mucosal damage in rats.
    Etienne A; Thonier F; Braquet P
    Int J Tissue React; 1989; 11(2):59-64. PubMed ID: 2693389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous injections of PAF-acether induce platelet aggregation in rats.
    Martins MA; Martins PM; Faria Neto HC; Bozza PT; Dias PM; Cordeiro RS; Vargaftig BB
    Eur J Pharmacol; 1988 Apr; 149(1-2):89-96. PubMed ID: 3135199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Involvement of PAF-acether in the anaphylactic shock in the rat.
    Damas J
    J Lipid Mediat; 1989; 1(3):161-70. PubMed ID: 2519891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microvascular actions of platelet-activating factor on rat gastric mucosa and submucosa.
    Whittle BJ; Morishita T; Ohya Y; Leung FW; Guth PH
    Am J Physiol; 1986 Dec; 251(6 Pt 1):G772-8. PubMed ID: 3789144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PF-5901 inhibits gastrointestinal platelet-activating factor synthesis in vivo.
    Hogaboam CM; Donigi-Gale D; Shoupe TS; Wallace JL
    Eur J Pharmacol; 1992 Jun; 216(2):315-8. PubMed ID: 1397016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in the rat blood leukocyte counts induced by PAF-acether is suppressed by general anesthesia.
    Bozza PT; Silva PM; Castro-Faria-Neto HC; Martins MA; Cordeiro RS
    J Leukoc Biol; 1992 Feb; 51(2):146-50. PubMed ID: 1431550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the role of platelet-activating factor in an animal model of inflammatory bowel disease.
    Wallace JL; Braquet P; Ibbotson GC; MacNaughton WK; Cirino G
    J Lipid Mediat; 1989; 1(1):13-23. PubMed ID: 2519884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of rat endotoxin-induced lethality by BN 52021 and BN 52063, compounds with PAF-acether antagonistic effect and protease-inhibitory activity.
    Etienne A; Hecquet F; Guilmard C; Soulard C; Braquet P
    Int J Tissue React; 1987; 9(1):19-26. PubMed ID: 3596954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet-activating factor-induced ischemic bowel necrosis: the effect of platelet-activating factor acetylhydrolase.
    Furukawa M; Lee EL; Johnston JM
    Pediatr Res; 1993 Aug; 34(2):237-41. PubMed ID: 8233731
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of neutrophils in gastric damage induced by platelet activating factor.
    Etienne A; Thonier F; Hecquet F; Braquet P
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):422-5. PubMed ID: 3244384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of senna is not mediated by platelet-activating factor.
    Capasso F; Izzo AA; Mascolo N; Autore G; Di Carlo G
    Pharmacology; 1993 Oct; 47 Suppl 1():58-63. PubMed ID: 8234442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
    László F; Whittle BJ; Moncada S
    Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan.
    Martins MA; Silva PM; Faria Neto HC; Bozza PT; Dias PM; Lima MC; Cordeiro RS; Vargaftig BB
    Br J Pharmacol; 1989 Feb; 96(2):363-71. PubMed ID: 2924083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone.
    Benhamou M; Ninio E; Salem P; Hieblot C; Bessou G; Pitton C; Liu FT; Mencia-Huerta JM
    J Immunol; 1986 Feb; 136(4):1385-92. PubMed ID: 2935578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Failure of prostaglandin E2 and its 16,16-dimethyl analogue to prevent the gastric mucosal damage induced by Paf.
    Steel G; Wallace JL; Whittle BJ
    Br J Pharmacol; 1987 Feb; 90(2):365-71. PubMed ID: 3470106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PAF formation by human gastrointestinal mucosa/submucosa in-vitro: release by ricinoleic acid, and inhibition by 5-aminosalicylic acid.
    Capasso F; Tavares IA; Bennett A
    J Pharm Pharmacol; 1992 Sep; 44(9):771-2. PubMed ID: 1360533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.
    Lefort J; Rotilio D; Vargaftig BB
    Br J Pharmacol; 1984 Jul; 82(3):565-75. PubMed ID: 6430375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of platelet-activating factor and its receptor antagonist, SRI 63-675, on gastric bleeding in rats.
    Berstad A; Almodovar K; Weatherstone RG; Hirschowitz BI
    Scand J Gastroenterol; 1988 Aug; 23(6):738-42. PubMed ID: 3262915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-activating factor mediates gastric damage induced by hemorrhagic shock.
    Wallace JL; Hogaboam CM; McKnight GW
    Am J Physiol; 1990 Jul; 259(1 Pt 1):G140-6. PubMed ID: 2372058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat.
    Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H
    Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.